About This Course
Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.
Successful completion of this course requires a score of 70% on the post-test.
This program is sponsored by an unrestricted educational grant from ResMed Inc.
Original Webcast Date: June 6, 2017
**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**
Identify interventions that reduce mortality in COPD
Discuss the impact of supplemental oxygen on COPD mortality
Discuss the methodology and outcomes of the LOTT study
Identify impact of the LOTT study on patient care
Chapters
A LOTT of Oxygen: An Update
Speaker Information
- Jerry Krishnan MD, PhD
Approved CRCE Hours
1.00
Category
Advertisement